News

Velocity Partners with Verified Clinical Trials to Combat Double Enrollment Problem in Clinical Trials

Velocity Clinical Research, the leading multi-specialty clinical research organization, has partnered with Verified Clinical Trials (VCT) to set a new benchmark for patient safety and data quality in clinical trials through a new technological implementation at Velocity’s 80+ global sites.  The collaboration addresses a critical industry challenge: the double enrollment of participants in multiple studies … Read more

Velocity at Scale Enrolls a Greater Number of Participants, Faster

In a recent global trial, Velocity sites enrolled participants 50% faster than the average trial site. Additionally, Velocity supported the trial with over 30 research sites across several countries. In another recent trial, Velocity’s 20 sites outpaced average trial site enrollment rate by nearly 80%. These achievements illustrate the power of Velocity at Scale — … Read more

Velocity is a Founding Member of the Association of MultiSite Research Corporations

We’re proud to announce that Velocity is a founding member of the newly launched Association of MultiSite Research Corporations (AMRC)! This innovative trade association unites 14 leading organizations to address the systemic challenges in clinical trials and drive meaningful change across the industry. With over 80 fully integrated research sites across the U.S. and Europe … Read more

Paul Evans Named Among the Top 50 Healthcare Technology CEOs of 2024

Congratulations to Paul Evans for being named one of the Top 50 Healthcare Technology CEOs of 2024! With Paul’s leadership, Velocity continues to redefine how clinical trials are conducted — leveraging VISION technology, centralization, and global site integration to accelerate drug development. His recognition by The Healthcare Technology Report is a nod to his vision … Read more

Velocity Contributes to ACRP Whitepaper on Responsible AI Oversight

Velocity’s team contributed to the new Association of Clinical Research Professionals (ACRP) comprehensive whitepaper, titled ‘Responsible Oversight of Artificial Intelligence for Clinical Research Professionals.’ The development of our VISION technology has coincided with the proliferation of AI and large language models (LLMs). For recruitment purposes, these tools have improved patient-trial matching, automated outreach, and enabled … Read more

BioSpace Opinion: The Cocktail Recipe That Will Cure Alzheimer’s

Robert Cupelo, MD, Principal Investigator in Syracuse, NY, shares his firsthand insights into the evolving landscape of Alzheimer’s treatment. Nearly two years after the FDA’s approval of lecanemab (Leqembi), and with the subsequent approval of donanemab (Kisunla), researchers are making crucial steps forward in the fight against disease progression and for disease prevention. In this … Read more

Fierce Biotech Article: Paul Evans on Clinical Trials in 2025

A new Fierce Biotech article features insights from Paul Evans on what to expect for clinical research in 2025. Topics include rising costs and uncertain regulations, as well as the continued emergence of site networks, AI-driven efficiency (with technology built “by trial sites, for trial sites”), and enhanced diversity initiatives. Read the article here: https://www.fiercebiotech.com/cro/clinical-trials-industry-set-uncertain-interconnected-2025-according-velocity-clinical-research

2025 Clinical Trials Outlook: Six Industry Trends to Expect

Rising costs, evolving regulations, and the unstoppable growth of AI are set to shape clinical trials in 2025. How will sites, new tech, promising obesity drugs, and shifting policies affect our industry? Read this article from Paul Evans featured on PharmiWeb: https://www.pharmiweb.com/article/2025-clinical-trials-outlook-six-industry-trends-to-expect

Henrik Watz Featured in Free Educational Presentation Available for HCPs on COPD with Type 2 Inflammation

Congratulations to Henrik Watz, MD, on his exceptional presentation at the 2024 European Respiratory Society (ERS) ADVENT COPD Symposia! Dr. Watz, Medical Director and Principal Investigator at Velocity Clinical Research in Ahrensburg, Germany, joined Drs. Mona Bafadhel and Alberto Papi for a dynamic discussion, A Breath of Fresh Air: A Greater Understanding of COPD With … Read more

Velocity Targets Latin America Expansion with the Appointment of Renata Berardocco as LATAM Managing Director

Velocity Clinical Research, the leading fully integrated clinical site organization, announces the appointment of Renata Berardocco as Executive Vice President and Managing Director for the Latin America (LATAM) region. Renata has nearly two decades of experience in senior leadership roles and joins from Fortrea, where she led Clinical Operations Delivery and Clinical Projects.  LATAM represents … Read more